It is showed that PRDX1 (peroxiredoxin 1), a ferroptosis promoter, combines with GPX2, MT3 (membrane receptor 3) and SRXN1 (sulfiredoxin 1) to establish an effective prognosis model for HCC (Luo et al., 2022). Here, PRDX1 is linked to hepatocellular carcinoma.